nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—peripheral nervous system neoplasm—malignant glioma	0.496	1	CtDrD
Epirubicin—TOP2A—malignant glioma	0.303	1	CbGaD
Epirubicin—CHD1—brainstem—malignant glioma	0.00198	0.0647	CbGeAlD
Epirubicin—CHD1—retina—malignant glioma	0.00191	0.0624	CbGeAlD
Epirubicin—CHD1—telencephalon—malignant glioma	0.00176	0.0574	CbGeAlD
Epirubicin—CHD1—medulla oblongata—malignant glioma	0.00138	0.0451	CbGeAlD
Epirubicin—DHCR7—retina—malignant glioma	0.00129	0.0421	CbGeAlD
Epirubicin—CHD1—midbrain—malignant glioma	0.00126	0.0412	CbGeAlD
Epirubicin—CHD1—spinal cord—malignant glioma	0.00123	0.0402	CbGeAlD
Epirubicin—DHCR7—telencephalon—malignant glioma	0.00119	0.0387	CbGeAlD
Epirubicin—YWHAG—retina—malignant glioma	0.00118	0.0386	CbGeAlD
Epirubicin—Valrubicin—TOP2A—malignant glioma	0.00114	0.267	CrCbGaD
Epirubicin—YWHAG—telencephalon—malignant glioma	0.00109	0.0355	CbGeAlD
Epirubicin—CHD1—central nervous system—malignant glioma	0.001	0.0326	CbGeAlD
Epirubicin—CHD1—cerebellum—malignant glioma	0.000978	0.0319	CbGeAlD
Epirubicin—DHCR7—medulla oblongata—malignant glioma	0.000933	0.0304	CbGeAlD
Epirubicin—Daunorubicin—POR—malignant glioma	0.000878	0.205	CrCbGaD
Epirubicin—YWHAG—medulla oblongata—malignant glioma	0.000856	0.0279	CbGeAlD
Epirubicin—DHCR7—midbrain—malignant glioma	0.000852	0.0278	CbGeAlD
Epirubicin—DHCR7—spinal cord—malignant glioma	0.000832	0.0271	CbGeAlD
Epirubicin—AURKA—central nervous system—malignant glioma	0.000806	0.0263	CbGeAlD
Epirubicin—CHD1—brain—malignant glioma	0.000794	0.0259	CbGeAlD
Epirubicin—YWHAG—midbrain—malignant glioma	0.000782	0.0255	CbGeAlD
Epirubicin—YWHAG—spinal cord—malignant glioma	0.000763	0.0249	CbGeAlD
Epirubicin—Doxorubicin—POR—malignant glioma	0.000713	0.166	CrCbGaD
Epirubicin—DHCR7—central nervous system—malignant glioma	0.000675	0.022	CbGeAlD
Epirubicin—DHCR7—cerebellum—malignant glioma	0.000659	0.0215	CbGeAlD
Epirubicin—Idarubicin—TOP2A—malignant glioma	0.000658	0.153	CrCbGaD
Epirubicin—AURKA—brain—malignant glioma	0.00064	0.0209	CbGeAlD
Epirubicin—PLA2G4A—medulla oblongata—malignant glioma	0.000638	0.0208	CbGeAlD
Epirubicin—YWHAG—central nervous system—malignant glioma	0.000619	0.0202	CbGeAlD
Epirubicin—YWHAG—cerebellum—malignant glioma	0.000605	0.0197	CbGeAlD
Epirubicin—PLA2G4A—midbrain—malignant glioma	0.000583	0.019	CbGeAlD
Epirubicin—PLA2G4A—spinal cord—malignant glioma	0.000569	0.0186	CbGeAlD
Epirubicin—Oral candidiasis—Carmustine—malignant glioma	0.000564	0.0061	CcSEcCtD
Epirubicin—Oral candidiasis—Temozolomide—malignant glioma	0.000545	0.0059	CcSEcCtD
Epirubicin—Embolism—Temozolomide—malignant glioma	0.00054	0.00584	CcSEcCtD
Epirubicin—Cyst—Carmustine—malignant glioma	0.000536	0.0058	CcSEcCtD
Epirubicin—DHCR7—brain—malignant glioma	0.000536	0.0175	CbGeAlD
Epirubicin—Parosmia—Temozolomide—malignant glioma	0.000534	0.00578	CcSEcCtD
Epirubicin—Hypokinesia—Carmustine—malignant glioma	0.000531	0.00574	CcSEcCtD
Epirubicin—Burning sensation—Carmustine—malignant glioma	0.000516	0.00558	CcSEcCtD
Epirubicin—Thrombosis—Carmustine—malignant glioma	0.000506	0.00548	CcSEcCtD
Epirubicin—YWHAG—brain—malignant glioma	0.000491	0.016	CbGeAlD
Epirubicin—Lung disorder—Temozolomide—malignant glioma	0.000489	0.00529	CcSEcCtD
Epirubicin—Scotoma—Carmustine—malignant glioma	0.000472	0.00511	CcSEcCtD
Epirubicin—Vaginal haemorrhage—Temozolomide—malignant glioma	0.000468	0.00506	CcSEcCtD
Epirubicin—ABCC1—telencephalon—malignant glioma	0.000465	0.0152	CbGeAlD
Epirubicin—PLA2G4A—central nervous system—malignant glioma	0.000462	0.0151	CbGeAlD
Epirubicin—Herpes zoster—Temozolomide—malignant glioma	0.00046	0.00498	CcSEcCtD
Epirubicin—Necrosis—Carmustine—malignant glioma	0.000457	0.00494	CcSEcCtD
Epirubicin—Scotoma—Temozolomide—malignant glioma	0.000456	0.00493	CcSEcCtD
Epirubicin—Abscess—Carmustine—malignant glioma	0.000453	0.0049	CcSEcCtD
Epirubicin—Otitis media—Temozolomide—malignant glioma	0.000445	0.00481	CcSEcCtD
Epirubicin—Hyperaesthesia—Temozolomide—malignant glioma	0.000441	0.00477	CcSEcCtD
Epirubicin—Injection site pain—Carmustine—malignant glioma	0.000439	0.00475	CcSEcCtD
Epirubicin—Rigors—Temozolomide—malignant glioma	0.000424	0.00459	CcSEcCtD
Epirubicin—Petechiae—Temozolomide—malignant glioma	0.000421	0.00455	CcSEcCtD
Epirubicin—Liver injury—Temozolomide—malignant glioma	0.000412	0.00445	CcSEcCtD
Epirubicin—Extravasation—Carmustine—malignant glioma	0.000411	0.00444	CcSEcCtD
Epirubicin—Breast pain—Temozolomide—malignant glioma	0.000397	0.0043	CcSEcCtD
Epirubicin—Amenorrhoea—Temozolomide—malignant glioma	0.000394	0.00426	CcSEcCtD
Epirubicin—Thinking abnormal—Carmustine—malignant glioma	0.000391	0.00424	CcSEcCtD
Epirubicin—Viral infection—Temozolomide—malignant glioma	0.000383	0.00415	CcSEcCtD
Epirubicin—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000381	0.00412	CcSEcCtD
Epirubicin—Herpes simplex—Temozolomide—malignant glioma	0.000376	0.00407	CcSEcCtD
Epirubicin—Gait disturbance—Carmustine—malignant glioma	0.000367	0.00397	CcSEcCtD
Epirubicin—PLA2G4A—brain—malignant glioma	0.000367	0.012	CbGeAlD
Epirubicin—Coordination abnormal—Carmustine—malignant glioma	0.000365	0.00395	CcSEcCtD
Epirubicin—Neck pain—Carmustine—malignant glioma	0.000363	0.00392	CcSEcCtD
Epirubicin—Pulmonary embolism—Carmustine—malignant glioma	0.000358	0.00388	CcSEcCtD
Epirubicin—Injection site reaction—Carmustine—malignant glioma	0.000356	0.00385	CcSEcCtD
Epirubicin—Gait disturbance—Temozolomide—malignant glioma	0.000355	0.00384	CcSEcCtD
Epirubicin—Coordination abnormal—Temozolomide—malignant glioma	0.000353	0.00382	CcSEcCtD
Epirubicin—Daunorubicin—TOP2A—malignant glioma	0.000353	0.0822	CrCbGaD
Epirubicin—Musculoskeletal pain—Temozolomide—malignant glioma	0.000351	0.00379	CcSEcCtD
Epirubicin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000346	0.00375	CcSEcCtD
Epirubicin—Vaginal inflammation—Temozolomide—malignant glioma	0.000346	0.00375	CcSEcCtD
Epirubicin—Pulmonary embolism—Temozolomide—malignant glioma	0.000346	0.00375	CcSEcCtD
Epirubicin—Skin exfoliation—Carmustine—malignant glioma	0.000342	0.0037	CcSEcCtD
Epirubicin—Candida infection—Carmustine—malignant glioma	0.000342	0.0037	CcSEcCtD
Epirubicin—Neuropathy—Carmustine—malignant glioma	0.000336	0.00364	CcSEcCtD
Epirubicin—Influenza like illness—Temozolomide—malignant glioma	0.000336	0.00364	CcSEcCtD
Epirubicin—Skin exfoliation—Temozolomide—malignant glioma	0.000331	0.00358	CcSEcCtD
Epirubicin—Candida infection—Temozolomide—malignant glioma	0.000331	0.00358	CcSEcCtD
Epirubicin—Coma—Carmustine—malignant glioma	0.000327	0.00354	CcSEcCtD
Epirubicin—Vaginal infection—Temozolomide—malignant glioma	0.000327	0.00354	CcSEcCtD
Epirubicin—Aplastic anaemia—Temozolomide—malignant glioma	0.000325	0.00352	CcSEcCtD
Epirubicin—Neuropathy—Temozolomide—malignant glioma	0.000325	0.00352	CcSEcCtD
Epirubicin—Neoplasm—Carmustine—malignant glioma	0.000324	0.00351	CcSEcCtD
Epirubicin—Dry eye—Temozolomide—malignant glioma	0.00032	0.00346	CcSEcCtD
Epirubicin—Neoplasm—Temozolomide—malignant glioma	0.000313	0.00339	CcSEcCtD
Epirubicin—Abnormal vision—Carmustine—malignant glioma	0.000313	0.00338	CcSEcCtD
Epirubicin—Mental disability—Carmustine—malignant glioma	0.000311	0.00337	CcSEcCtD
Epirubicin—Sepsis—Carmustine—malignant glioma	0.000311	0.00337	CcSEcCtD
Epirubicin—Abnormal vision—Temozolomide—malignant glioma	0.000302	0.00327	CcSEcCtD
Epirubicin—Phlebitis—Carmustine—malignant glioma	0.000302	0.00327	CcSEcCtD
Epirubicin—Mental disability—Temozolomide—malignant glioma	0.000301	0.00325	CcSEcCtD
Epirubicin—Thrombophlebitis—Carmustine—malignant glioma	0.000301	0.00325	CcSEcCtD
Epirubicin—Diabetes mellitus—Carmustine—malignant glioma	0.000299	0.00324	CcSEcCtD
Epirubicin—Thrombophlebitis—Temozolomide—malignant glioma	0.00029	0.00314	CcSEcCtD
Epirubicin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000289	0.00313	CcSEcCtD
Epirubicin—Eye pain—Carmustine—malignant glioma	0.000288	0.00312	CcSEcCtD
Epirubicin—Doxorubicin—TOP2A—malignant glioma	0.000286	0.0668	CrCbGaD
Epirubicin—Vascular purpura—Temozolomide—malignant glioma	0.000281	0.00304	CcSEcCtD
Epirubicin—Hepatic failure—Temozolomide—malignant glioma	0.00028	0.00303	CcSEcCtD
Epirubicin—Eye pain—Temozolomide—malignant glioma	0.000278	0.00301	CcSEcCtD
Epirubicin—Hot flush—Temozolomide—malignant glioma	0.000269	0.00291	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000266	0.00288	CcSEcCtD
Epirubicin—Menopausal symptoms—Temozolomide—malignant glioma	0.000266	0.00288	CcSEcCtD
Epirubicin—Hyponatraemia—Carmustine—malignant glioma	0.000261	0.00283	CcSEcCtD
Epirubicin—Purpura—Temozolomide—malignant glioma	0.000261	0.00282	CcSEcCtD
Epirubicin—Diplopia—Carmustine—malignant glioma	0.00026	0.00281	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00026	0.00281	CcSEcCtD
Epirubicin—ABCC1—cerebellum—malignant glioma	0.000258	0.00842	CbGeAlD
Epirubicin—Doxorubicin—CYP2B6—malignant glioma	0.000255	0.0594	CrCbGaD
Epirubicin—Diplopia—Temozolomide—malignant glioma	0.000251	0.00272	CcSEcCtD
Epirubicin—Face oedema—Carmustine—malignant glioma	0.000251	0.00272	CcSEcCtD
Epirubicin—Affect lability—Temozolomide—malignant glioma	0.000247	0.00268	CcSEcCtD
Epirubicin—Ataxia—Carmustine—malignant glioma	0.000245	0.00265	CcSEcCtD
Epirubicin—Face oedema—Temozolomide—malignant glioma	0.000243	0.00263	CcSEcCtD
Epirubicin—Liver function test abnormal—Carmustine—malignant glioma	0.00024	0.0026	CcSEcCtD
Epirubicin—Mood swings—Temozolomide—malignant glioma	0.000238	0.00258	CcSEcCtD
Epirubicin—Hypokalaemia—Carmustine—malignant glioma	0.000237	0.00256	CcSEcCtD
Epirubicin—Ataxia—Temozolomide—malignant glioma	0.000236	0.00256	CcSEcCtD
Epirubicin—Dehydration—Temozolomide—malignant glioma	0.000234	0.00253	CcSEcCtD
Epirubicin—Dry skin—Temozolomide—malignant glioma	0.00023	0.00249	CcSEcCtD
Epirubicin—Muscular weakness—Carmustine—malignant glioma	0.000229	0.00248	CcSEcCtD
Epirubicin—Hypokalaemia—Temozolomide—malignant glioma	0.000229	0.00248	CcSEcCtD
Epirubicin—Breast disorder—Temozolomide—malignant glioma	0.000227	0.00246	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000226	0.00245	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000226	0.00245	CcSEcCtD
Epirubicin—Dysphagia—Carmustine—malignant glioma	0.000225	0.00243	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000222	0.0024	CcSEcCtD
Epirubicin—Muscular weakness—Temozolomide—malignant glioma	0.000222	0.0024	CcSEcCtD
Epirubicin—Abdominal distension—Temozolomide—malignant glioma	0.000219	0.00237	CcSEcCtD
Epirubicin—Dysphagia—Temozolomide—malignant glioma	0.000217	0.00235	CcSEcCtD
Epirubicin—Pancytopenia—Carmustine—malignant glioma	0.000214	0.00231	CcSEcCtD
Epirubicin—Neutropenia—Carmustine—malignant glioma	0.00021	0.00227	CcSEcCtD
Epirubicin—ABCC1—brain—malignant glioma	0.00021	0.00684	CbGeAlD
Epirubicin—Bronchitis—Temozolomide—malignant glioma	0.000209	0.00226	CcSEcCtD
Epirubicin—Pancytopenia—Temozolomide—malignant glioma	0.000206	0.00223	CcSEcCtD
Epirubicin—Dysuria—Temozolomide—malignant glioma	0.000203	0.0022	CcSEcCtD
Epirubicin—Neutropenia—Temozolomide—malignant glioma	0.000203	0.0022	CcSEcCtD
Epirubicin—Hyperglycaemia—Carmustine—malignant glioma	0.000203	0.00219	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000202	0.00219	CcSEcCtD
Epirubicin—Pneumonia—Carmustine—malignant glioma	0.000202	0.00218	CcSEcCtD
Epirubicin—Pollakiuria—Temozolomide—malignant glioma	0.000201	0.00217	CcSEcCtD
Epirubicin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000198	0.00215	CcSEcCtD
Epirubicin—Weight increased—Temozolomide—malignant glioma	0.000198	0.00214	CcSEcCtD
Epirubicin—Renal failure—Carmustine—malignant glioma	0.000197	0.00213	CcSEcCtD
Epirubicin—Weight decreased—Temozolomide—malignant glioma	0.000197	0.00213	CcSEcCtD
Epirubicin—Neuropathy peripheral—Carmustine—malignant glioma	0.000197	0.00213	CcSEcCtD
Epirubicin—Hyperglycaemia—Temozolomide—malignant glioma	0.000196	0.00212	CcSEcCtD
Epirubicin—Stomatitis—Carmustine—malignant glioma	0.000195	0.00211	CcSEcCtD
Epirubicin—Urinary tract infection—Carmustine—malignant glioma	0.000195	0.00211	CcSEcCtD
Epirubicin—Pneumonia—Temozolomide—malignant glioma	0.000195	0.00211	CcSEcCtD
Epirubicin—Infestation NOS—Temozolomide—malignant glioma	0.000194	0.0021	CcSEcCtD
Epirubicin—Infestation—Temozolomide—malignant glioma	0.000194	0.0021	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000192	0.00208	CcSEcCtD
Epirubicin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00019	0.00205	CcSEcCtD
Epirubicin—Stomatitis—Temozolomide—malignant glioma	0.000189	0.00204	CcSEcCtD
Epirubicin—Urinary tract infection—Temozolomide—malignant glioma	0.000188	0.00204	CcSEcCtD
Epirubicin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000183	0.00198	CcSEcCtD
Epirubicin—Sinusitis—Temozolomide—malignant glioma	0.000182	0.00197	CcSEcCtD
Epirubicin—Haemoglobin—Carmustine—malignant glioma	0.000181	0.00196	CcSEcCtD
Epirubicin—Haemorrhage—Carmustine—malignant glioma	0.00018	0.00195	CcSEcCtD
Epirubicin—Hypoaesthesia—Carmustine—malignant glioma	0.000179	0.00194	CcSEcCtD
Epirubicin—Oedema peripheral—Carmustine—malignant glioma	0.000177	0.00192	CcSEcCtD
Epirubicin—Connective tissue disorder—Carmustine—malignant glioma	0.000177	0.00191	CcSEcCtD
Epirubicin—Haemoglobin—Temozolomide—malignant glioma	0.000175	0.00189	CcSEcCtD
Epirubicin—Hepatitis—Temozolomide—malignant glioma	0.000174	0.00188	CcSEcCtD
Epirubicin—Haemorrhage—Temozolomide—malignant glioma	0.000174	0.00188	CcSEcCtD
Epirubicin—Visual impairment—Carmustine—malignant glioma	0.000173	0.00188	CcSEcCtD
Epirubicin—Hypoaesthesia—Temozolomide—malignant glioma	0.000173	0.00187	CcSEcCtD
Epirubicin—Pharyngitis—Temozolomide—malignant glioma	0.000173	0.00187	CcSEcCtD
Epirubicin—Urinary tract disorder—Temozolomide—malignant glioma	0.000172	0.00186	CcSEcCtD
Epirubicin—Oedema peripheral—Temozolomide—malignant glioma	0.000171	0.00185	CcSEcCtD
Epirubicin—Connective tissue disorder—Temozolomide—malignant glioma	0.000171	0.00185	CcSEcCtD
Epirubicin—Urethral disorder—Temozolomide—malignant glioma	0.00017	0.00184	CcSEcCtD
Epirubicin—Eye disorder—Carmustine—malignant glioma	0.000168	0.00182	CcSEcCtD
Epirubicin—Visual impairment—Temozolomide—malignant glioma	0.000168	0.00181	CcSEcCtD
Epirubicin—Flushing—Carmustine—malignant glioma	0.000167	0.00181	CcSEcCtD
Epirubicin—Erythema multiforme—Temozolomide—malignant glioma	0.000164	0.00178	CcSEcCtD
Epirubicin—Eye disorder—Temozolomide—malignant glioma	0.000163	0.00176	CcSEcCtD
Epirubicin—Tinnitus—Temozolomide—malignant glioma	0.000162	0.00175	CcSEcCtD
Epirubicin—Cardiac disorder—Temozolomide—malignant glioma	0.000161	0.00175	CcSEcCtD
Epirubicin—Flushing—Temozolomide—malignant glioma	0.000161	0.00175	CcSEcCtD
Epirubicin—Arrhythmia—Carmustine—malignant glioma	0.000161	0.00174	CcSEcCtD
Epirubicin—Alopecia—Carmustine—malignant glioma	0.000159	0.00172	CcSEcCtD
Epirubicin—Angiopathy—Temozolomide—malignant glioma	0.000158	0.00171	CcSEcCtD
Epirubicin—Mental disorder—Carmustine—malignant glioma	0.000158	0.00171	CcSEcCtD
Epirubicin—Immune system disorder—Temozolomide—malignant glioma	0.000157	0.0017	CcSEcCtD
Epirubicin—Mediastinal disorder—Temozolomide—malignant glioma	0.000157	0.0017	CcSEcCtD
Epirubicin—Erythema—Carmustine—malignant glioma	0.000157	0.0017	CcSEcCtD
Epirubicin—Malnutrition—Carmustine—malignant glioma	0.000157	0.0017	CcSEcCtD
Epirubicin—Chills—Temozolomide—malignant glioma	0.000156	0.00169	CcSEcCtD
Epirubicin—Alopecia—Temozolomide—malignant glioma	0.000154	0.00166	CcSEcCtD
Epirubicin—Mental disorder—Temozolomide—malignant glioma	0.000152	0.00165	CcSEcCtD
Epirubicin—Back pain—Carmustine—malignant glioma	0.000152	0.00164	CcSEcCtD
Epirubicin—Erythema—Temozolomide—malignant glioma	0.000151	0.00164	CcSEcCtD
Epirubicin—Malnutrition—Temozolomide—malignant glioma	0.000151	0.00164	CcSEcCtD
Epirubicin—Dysgeusia—Temozolomide—malignant glioma	0.000148	0.0016	CcSEcCtD
Epirubicin—Vision blurred—Carmustine—malignant glioma	0.000148	0.0016	CcSEcCtD
Epirubicin—Back pain—Temozolomide—malignant glioma	0.000146	0.00158	CcSEcCtD
Epirubicin—Anaemia—Carmustine—malignant glioma	0.000145	0.00157	CcSEcCtD
Epirubicin—Agitation—Carmustine—malignant glioma	0.000144	0.00156	CcSEcCtD
Epirubicin—Vision blurred—Temozolomide—malignant glioma	0.000143	0.00154	CcSEcCtD
Epirubicin—Ill-defined disorder—Temozolomide—malignant glioma	0.00014	0.00152	CcSEcCtD
Epirubicin—Leukopenia—Carmustine—malignant glioma	0.00014	0.00152	CcSEcCtD
Epirubicin—Anaemia—Temozolomide—malignant glioma	0.00014	0.00151	CcSEcCtD
Epirubicin—Agitation—Temozolomide—malignant glioma	0.000139	0.00151	CcSEcCtD
Epirubicin—Malaise—Temozolomide—malignant glioma	0.000137	0.00148	CcSEcCtD
Epirubicin—Vertigo—Temozolomide—malignant glioma	0.000136	0.00147	CcSEcCtD
Epirubicin—Convulsion—Carmustine—malignant glioma	0.000136	0.00147	CcSEcCtD
Epirubicin—Leukopenia—Temozolomide—malignant glioma	0.000136	0.00147	CcSEcCtD
Epirubicin—Hypertension—Carmustine—malignant glioma	0.000135	0.00146	CcSEcCtD
Epirubicin—Palpitations—Temozolomide—malignant glioma	0.000134	0.00145	CcSEcCtD
Epirubicin—Chest pain—Carmustine—malignant glioma	0.000133	0.00144	CcSEcCtD
Epirubicin—Myalgia—Carmustine—malignant glioma	0.000133	0.00144	CcSEcCtD
Epirubicin—Anxiety—Carmustine—malignant glioma	0.000133	0.00144	CcSEcCtD
Epirubicin—Cough—Temozolomide—malignant glioma	0.000132	0.00143	CcSEcCtD
Epirubicin—Convulsion—Temozolomide—malignant glioma	0.000131	0.00142	CcSEcCtD
Epirubicin—Hypertension—Temozolomide—malignant glioma	0.000131	0.00141	CcSEcCtD
Epirubicin—Confusional state—Carmustine—malignant glioma	0.000129	0.00139	CcSEcCtD
Epirubicin—Myalgia—Temozolomide—malignant glioma	0.000129	0.00139	CcSEcCtD
Epirubicin—Arthralgia—Temozolomide—malignant glioma	0.000129	0.00139	CcSEcCtD
Epirubicin—Anxiety—Temozolomide—malignant glioma	0.000128	0.00139	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000128	0.00139	CcSEcCtD
Epirubicin—Oedema—Carmustine—malignant glioma	0.000128	0.00138	CcSEcCtD
Epirubicin—Discomfort—Temozolomide—malignant glioma	0.000127	0.00138	CcSEcCtD
Epirubicin—Infection—Carmustine—malignant glioma	0.000127	0.00137	CcSEcCtD
Epirubicin—Dry mouth—Temozolomide—malignant glioma	0.000126	0.00136	CcSEcCtD
Epirubicin—Thrombocytopenia—Carmustine—malignant glioma	0.000125	0.00135	CcSEcCtD
Epirubicin—Tachycardia—Carmustine—malignant glioma	0.000125	0.00135	CcSEcCtD
Epirubicin—Confusional state—Temozolomide—malignant glioma	0.000125	0.00135	CcSEcCtD
Epirubicin—Anaphylactic shock—Temozolomide—malignant glioma	0.000124	0.00134	CcSEcCtD
Epirubicin—Oedema—Temozolomide—malignant glioma	0.000124	0.00134	CcSEcCtD
Epirubicin—Infection—Temozolomide—malignant glioma	0.000123	0.00133	CcSEcCtD
Epirubicin—Anorexia—Carmustine—malignant glioma	0.000122	0.00132	CcSEcCtD
Epirubicin—Nervous system disorder—Temozolomide—malignant glioma	0.000121	0.00131	CcSEcCtD
Epirubicin—Thrombocytopenia—Temozolomide—malignant glioma	0.000121	0.00131	CcSEcCtD
Epirubicin—Skin disorder—Temozolomide—malignant glioma	0.00012	0.0013	CcSEcCtD
Epirubicin—Hypotension—Carmustine—malignant glioma	0.000119	0.00129	CcSEcCtD
Epirubicin—Hyperhidrosis—Temozolomide—malignant glioma	0.000119	0.00129	CcSEcCtD
Epirubicin—Anorexia—Temozolomide—malignant glioma	0.000118	0.00127	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000116	0.00126	CcSEcCtD
Epirubicin—Insomnia—Carmustine—malignant glioma	0.000116	0.00125	CcSEcCtD
Epirubicin—Paraesthesia—Carmustine—malignant glioma	0.000115	0.00124	CcSEcCtD
Epirubicin—Dyspnoea—Carmustine—malignant glioma	0.000114	0.00123	CcSEcCtD
Epirubicin—Somnolence—Carmustine—malignant glioma	0.000114	0.00123	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000113	0.00122	CcSEcCtD
Epirubicin—Insomnia—Temozolomide—malignant glioma	0.000112	0.00121	CcSEcCtD
Epirubicin—Decreased appetite—Carmustine—malignant glioma	0.000111	0.0012	CcSEcCtD
Epirubicin—Paraesthesia—Temozolomide—malignant glioma	0.000111	0.0012	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00011	0.00119	CcSEcCtD
Epirubicin—Dyspnoea—Temozolomide—malignant glioma	0.00011	0.00119	CcSEcCtD
Epirubicin—Somnolence—Temozolomide—malignant glioma	0.00011	0.00119	CcSEcCtD
Epirubicin—Constipation—Carmustine—malignant glioma	0.000109	0.00118	CcSEcCtD
Epirubicin—Pain—Carmustine—malignant glioma	0.000109	0.00118	CcSEcCtD
Epirubicin—Dyspepsia—Temozolomide—malignant glioma	0.000109	0.00118	CcSEcCtD
Epirubicin—Decreased appetite—Temozolomide—malignant glioma	0.000107	0.00116	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000107	0.00115	CcSEcCtD
Epirubicin—Fatigue—Temozolomide—malignant glioma	0.000107	0.00115	CcSEcCtD
Epirubicin—Pain—Temozolomide—malignant glioma	0.000106	0.00114	CcSEcCtD
Epirubicin—Constipation—Temozolomide—malignant glioma	0.000106	0.00114	CcSEcCtD
Epirubicin—Feeling abnormal—Carmustine—malignant glioma	0.000105	0.00114	CcSEcCtD
Epirubicin—Gastrointestinal pain—Carmustine—malignant glioma	0.000105	0.00113	CcSEcCtD
Epirubicin—Feeling abnormal—Temozolomide—malignant glioma	0.000102	0.0011	CcSEcCtD
Epirubicin—Abdominal pain—Carmustine—malignant glioma	0.000101	0.00109	CcSEcCtD
Epirubicin—Body temperature increased—Carmustine—malignant glioma	0.000101	0.00109	CcSEcCtD
Epirubicin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000101	0.00109	CcSEcCtD
Epirubicin—Urticaria—Temozolomide—malignant glioma	9.82e-05	0.00106	CcSEcCtD
Epirubicin—Body temperature increased—Temozolomide—malignant glioma	9.77e-05	0.00106	CcSEcCtD
Epirubicin—Abdominal pain—Temozolomide—malignant glioma	9.77e-05	0.00106	CcSEcCtD
Epirubicin—Hypersensitivity—Carmustine—malignant glioma	9.42e-05	0.00102	CcSEcCtD
Epirubicin—Asthenia—Carmustine—malignant glioma	9.17e-05	0.000993	CcSEcCtD
Epirubicin—Hypersensitivity—Temozolomide—malignant glioma	9.1e-05	0.000985	CcSEcCtD
Epirubicin—Asthenia—Temozolomide—malignant glioma	8.87e-05	0.000959	CcSEcCtD
Epirubicin—Diarrhoea—Carmustine—malignant glioma	8.75e-05	0.000947	CcSEcCtD
Epirubicin—Pruritus—Temozolomide—malignant glioma	8.74e-05	0.000946	CcSEcCtD
Epirubicin—Dizziness—Carmustine—malignant glioma	8.46e-05	0.000915	CcSEcCtD
Epirubicin—Diarrhoea—Temozolomide—malignant glioma	8.45e-05	0.000915	CcSEcCtD
Epirubicin—Dizziness—Temozolomide—malignant glioma	8.17e-05	0.000884	CcSEcCtD
Epirubicin—Vomiting—Carmustine—malignant glioma	8.13e-05	0.00088	CcSEcCtD
Epirubicin—Rash—Carmustine—malignant glioma	8.06e-05	0.000872	CcSEcCtD
Epirubicin—Dermatitis—Carmustine—malignant glioma	8.05e-05	0.000872	CcSEcCtD
Epirubicin—Headache—Carmustine—malignant glioma	8.01e-05	0.000867	CcSEcCtD
Epirubicin—Vomiting—Temozolomide—malignant glioma	7.86e-05	0.00085	CcSEcCtD
Epirubicin—Rash—Temozolomide—malignant glioma	7.79e-05	0.000843	CcSEcCtD
Epirubicin—Dermatitis—Temozolomide—malignant glioma	7.78e-05	0.000842	CcSEcCtD
Epirubicin—Headache—Temozolomide—malignant glioma	7.74e-05	0.000838	CcSEcCtD
Epirubicin—Nausea—Carmustine—malignant glioma	7.59e-05	0.000822	CcSEcCtD
Epirubicin—Nausea—Temozolomide—malignant glioma	7.34e-05	0.000794	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—DTX1—malignant glioma	2.14e-05	0.00029	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.11e-05	0.000286	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.1e-05	0.000285	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CG—malignant glioma	2.1e-05	0.000285	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.06e-05	0.00028	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.06e-05	0.000279	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.04e-05	0.000276	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PDGFB—malignant glioma	2.03e-05	0.000276	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PPARG—malignant glioma	2.03e-05	0.000275	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—IDH1—malignant glioma	2e-05	0.000271	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2e-05	0.000271	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—malignant glioma	1.98e-05	0.000269	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—IDH1—malignant glioma	1.96e-05	0.000266	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.96e-05	0.000266	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCR3—malignant glioma	1.96e-05	0.000265	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.95e-05	0.000264	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SPHK1—malignant glioma	1.94e-05	0.000263	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CAV1—malignant glioma	1.93e-05	0.000261	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HEY2—malignant glioma	1.92e-05	0.00026	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	1.92e-05	0.00026	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SPHK1—malignant glioma	1.9e-05	0.000257	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2C18—malignant glioma	1.9e-05	0.000257	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IDH1—malignant glioma	1.87e-05	0.000254	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2C18—malignant glioma	1.86e-05	0.000252	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CD—malignant glioma	1.85e-05	0.000251	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—F2—malignant glioma	1.83e-05	0.000249	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—FN1—malignant glioma	1.83e-05	0.000249	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—IDH2—malignant glioma	1.82e-05	0.000247	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—BDKRB2—malignant glioma	1.79e-05	0.000243	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.79e-05	0.000242	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HEY1—malignant glioma	1.77e-05	0.000241	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CG—malignant glioma	1.75e-05	0.000238	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.75e-05	0.000238	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	1.74e-05	0.000235	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—EGF—malignant glioma	1.73e-05	0.000235	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.73e-05	0.000234	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PTPN11—malignant glioma	1.72e-05	0.000234	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIST1H3B—malignant glioma	1.72e-05	0.000234	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.72e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2B6—malignant glioma	1.71e-05	0.000232	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SUFU—malignant glioma	1.7e-05	0.000231	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.69e-05	0.000229	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—malignant glioma	1.68e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HEY2—malignant glioma	1.68e-05	0.000228	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GFAP—malignant glioma	1.64e-05	0.000223	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—malignant glioma	1.63e-05	0.000221	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KNG1—malignant glioma	1.63e-05	0.000221	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CB—malignant glioma	1.61e-05	0.000218	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT2—malignant glioma	1.61e-05	0.000218	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.6e-05	0.000217	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS2—malignant glioma	1.6e-05	0.000216	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.59e-05	0.000216	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPHK1—malignant glioma	1.59e-05	0.000215	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JAG2—malignant glioma	1.57e-05	0.000213	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—IDH1—malignant glioma	1.57e-05	0.000213	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR4—malignant glioma	1.56e-05	0.000211	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HEY1—malignant glioma	1.56e-05	0.000211	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	1.55e-05	0.000211	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CD—malignant glioma	1.54e-05	0.000209	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.54e-05	0.000209	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—malignant glioma	1.53e-05	0.000208	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SPHK1—malignant glioma	1.52e-05	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIST1H3B—malignant glioma	1.51e-05	0.000205	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MDM2—malignant glioma	1.51e-05	0.000204	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTT1—malignant glioma	1.5e-05	0.000204	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—malignant glioma	1.5e-05	0.000204	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2C18—malignant glioma	1.49e-05	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.46e-05	0.000198	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MMP3—malignant glioma	1.44e-05	0.000196	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS1—malignant glioma	1.44e-05	0.000195	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS1—malignant glioma	1.41e-05	0.000191	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.4e-05	0.00019	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.4e-05	0.00019	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTEN—malignant glioma	1.39e-05	0.000189	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JAG2—malignant glioma	1.38e-05	0.000187	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RAF1—malignant glioma	1.38e-05	0.000187	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CB—malignant glioma	1.34e-05	0.000182	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—BCHE—malignant glioma	1.34e-05	0.000181	CbGpPWpGaD
Epirubicin—ABCC1—Disease—H3F3A—malignant glioma	1.33e-05	0.000181	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC5A5—malignant glioma	1.32e-05	0.000179	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—BCHE—malignant glioma	1.31e-05	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.3e-05	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC5A5—malignant glioma	1.29e-05	0.000176	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.28e-05	0.000173	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JAG1—malignant glioma	1.26e-05	0.00017	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—malignant glioma	1.24e-05	0.000168	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—malignant glioma	1.23e-05	0.000167	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.23e-05	0.000167	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FBXW7—malignant glioma	1.23e-05	0.000167	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.22e-05	0.000166	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.21e-05	0.000165	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—malignant glioma	1.2e-05	0.000163	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	1.18e-05	0.00016	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—H3F3A—malignant glioma	1.17e-05	0.000158	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR3—malignant glioma	1.16e-05	0.000157	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS1—malignant glioma	1.13e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK2—malignant glioma	1.12e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—YWHAE—malignant glioma	1.12e-05	0.000153	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.12e-05	0.000152	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FLT1—malignant glioma	1.12e-05	0.000152	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DUSP6—malignant glioma	1.11e-05	0.000151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JAG1—malignant glioma	1.1e-05	0.000149	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH3—malignant glioma	1.1e-05	0.000149	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FBXW7—malignant glioma	1.08e-05	0.000146	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTP1—malignant glioma	1.06e-05	0.000144	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.06e-05	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BDKRB2—malignant glioma	1.06e-05	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—malignant glioma	1.05e-05	0.000143	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—malignant glioma	1.05e-05	0.000143	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—malignant glioma	1.05e-05	0.000142	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BCHE—malignant glioma	1.05e-05	0.000142	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTP1—malignant glioma	1.04e-05	0.000141	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAT—malignant glioma	1.03e-05	0.00014	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC5A5—malignant glioma	1.03e-05	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAT—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CG—malignant glioma	1.01e-05	0.000137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTPN11—malignant glioma	9.89e-06	0.000134	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH2—malignant glioma	9.83e-06	0.000133	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—malignant glioma	9.82e-06	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.78e-06	0.000133	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NCOR1—malignant glioma	9.77e-06	0.000133	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.69e-06	0.000131	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN2B—malignant glioma	9.64e-06	0.000131	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KNG1—malignant glioma	9.62e-06	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NCOR1—malignant glioma	9.58e-06	0.00013	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	9.53e-06	0.000129	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT2—malignant glioma	9.21e-06	0.000125	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HES1—malignant glioma	9.19e-06	0.000125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK1—malignant glioma	9.17e-06	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NCOR1—malignant glioma	9.14e-06	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KRAS—malignant glioma	8.92e-06	0.000121	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CD—malignant glioma	8.85e-06	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PDGFRA—malignant glioma	8.75e-06	0.000119	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—malignant glioma	8.64e-06	0.000117	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP3—malignant glioma	8.52e-06	0.000116	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.45e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN2B—malignant glioma	8.45e-06	0.000115	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—malignant glioma	8.33e-06	0.000113	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTK2—malignant glioma	8.2e-06	0.000111	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—malignant glioma	8.2e-06	0.000111	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAT—malignant glioma	8.11e-06	0.00011	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HES1—malignant glioma	8.06e-06	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TERT—malignant glioma	8.06e-06	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HLA-A—malignant glioma	8.06e-06	0.000109	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—malignant glioma	8.02e-06	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NCOR1—malignant glioma	8.01e-06	0.000109	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAV1—malignant glioma	7.96e-06	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—malignant glioma	7.93e-06	0.000108	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RAF1—malignant glioma	7.9e-06	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PDGFB—malignant glioma	7.86e-06	0.000107	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGFR1—malignant glioma	7.82e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAV1—malignant glioma	7.81e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CB—malignant glioma	7.72e-06	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIF1A—malignant glioma	7.7e-06	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDGFRA—malignant glioma	7.67e-06	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NCOR1—malignant glioma	7.66e-06	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.46e-06	0.000101	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CAV1—malignant glioma	7.45e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—malignant glioma	7.45e-06	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—malignant glioma	7.42e-06	0.000101	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CG—malignant glioma	7.25e-06	9.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CG—malignant glioma	7.11e-06	9.65e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—malignant glioma	7.09e-06	9.61e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TERT—malignant glioma	7.06e-06	9.58e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BAD—malignant glioma	7.01e-06	9.51e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—malignant glioma	7e-06	9.5e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOTCH1—malignant glioma	6.94e-06	9.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDGFB—malignant glioma	6.89e-06	9.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—malignant glioma	6.87e-06	9.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGFR1—malignant glioma	6.86e-06	9.3e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD80—malignant glioma	6.8e-06	9.22e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APC—malignant glioma	6.79e-06	9.21e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—malignant glioma	6.75e-06	9.16e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGF—malignant glioma	6.71e-06	9.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—malignant glioma	6.7e-06	9.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTPN11—malignant glioma	6.67e-06	9.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CAV1—malignant glioma	6.53e-06	8.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—malignant glioma	6.46e-06	8.76e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BRAF—malignant glioma	6.38e-06	8.65e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CD—malignant glioma	6.38e-06	8.65e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CD—malignant glioma	6.25e-06	8.48e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAV1—malignant glioma	6.24e-06	8.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—malignant glioma	6.22e-06	8.43e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—malignant glioma	6.22e-06	8.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT2—malignant glioma	6.21e-06	8.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BAD—malignant glioma	6.14e-06	8.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH1—malignant glioma	6.08e-06	8.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CD—malignant glioma	5.97e-06	8.09e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.96e-06	8.09e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD80—malignant glioma	5.96e-06	8.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CG—malignant glioma	5.95e-06	8.07e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APC—malignant glioma	5.95e-06	8.07e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGF—malignant glioma	5.88e-06	7.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTPN11—malignant glioma	5.84e-06	7.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF2—malignant glioma	5.71e-06	7.75e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CG—malignant glioma	5.68e-06	7.71e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BRAF—malignant glioma	5.59e-06	7.58e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CB—malignant glioma	5.56e-06	7.54e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—malignant glioma	5.51e-06	7.47e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—malignant glioma	5.49e-06	7.44e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CB—malignant glioma	5.45e-06	7.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT2—malignant glioma	5.44e-06	7.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—malignant glioma	5.42e-06	7.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—malignant glioma	5.4e-06	7.33e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MDM2—malignant glioma	5.35e-06	7.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RAF1—malignant glioma	5.33e-06	7.23e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB2—malignant glioma	5.27e-06	7.15e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CD—malignant glioma	5.23e-06	7.09e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CB—malignant glioma	5.2e-06	7.05e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—malignant glioma	5.15e-06	6.99e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—malignant glioma	5.12e-06	6.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF2—malignant glioma	5.01e-06	6.79e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CD—malignant glioma	5e-06	6.78e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTEN—malignant glioma	4.8e-06	6.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTEN—malignant glioma	4.71e-06	6.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—malignant glioma	4.7e-06	6.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MDM2—malignant glioma	4.69e-06	6.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAF1—malignant glioma	4.67e-06	6.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—malignant glioma	4.62e-06	6.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CB—malignant glioma	4.56e-06	6.18e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTEN—malignant glioma	4.49e-06	6.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—malignant glioma	4.38e-06	5.94e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CB—malignant glioma	4.36e-06	5.91e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—malignant glioma	4.32e-06	5.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—malignant glioma	4.19e-06	5.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—malignant glioma	4.19e-06	5.68e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—malignant glioma	4.02e-06	5.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—malignant glioma	3.96e-06	5.37e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTEN—malignant glioma	3.94e-06	5.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—malignant glioma	3.84e-06	5.21e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTEN—malignant glioma	3.76e-06	5.11e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—malignant glioma	3.73e-06	5.07e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—malignant glioma	3.65e-06	4.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—malignant glioma	3.56e-06	4.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—malignant glioma	3.52e-06	4.78e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—malignant glioma	3.45e-06	4.68e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—malignant glioma	3.39e-06	4.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—malignant glioma	3.32e-06	4.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—malignant glioma	3.27e-06	4.44e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—malignant glioma	3.2e-06	4.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—malignant glioma	3.17e-06	4.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—malignant glioma	3.02e-06	4.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—malignant glioma	2.78e-06	3.77e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—malignant glioma	2.77e-06	3.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—malignant glioma	2.71e-06	3.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—malignant glioma	2.69e-06	3.65e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—malignant glioma	2.66e-06	3.6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—malignant glioma	2.59e-06	3.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—malignant glioma	2.27e-06	3.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—malignant glioma	2.17e-06	2.94e-05	CbGpPWpGaD
